These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22665498)

  • 21. Gleevec target Abl important for normal immune activation of T cells.
    Cancer Biol Ther; 2004 Aug; 3(8):704. PubMed ID: 15751157
    [No Abstract]   [Full Text] [Related]  

  • 22. Leishmania mexicana infection induces IgG to parasite surface glycoinositol phospholipids that can induce IL-10 in mice and humans.
    Buxbaum LU
    PLoS Negl Trop Dis; 2013; 7(5):e2224. PubMed ID: 23675550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dectin-1 Activation during
    Lima-Junior DS; Mineo TWP; Calich VLG; Zamboni DS
    J Immunol; 2017 Sep; 199(6):2055-2068. PubMed ID: 28784846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages.
    Da Silva RP; Hall BF; Joiner KA; Sacks DL
    J Immunol; 1989 Jul; 143(2):617-22. PubMed ID: 2525590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase G increases antioxidant function in lung microvascular endothelial cells by inhibiting the c-Abl tyrosine kinase.
    Stephens RS; Servinsky LE; Rentsendorj O; Kolb TM; Pfeifer A; Pearse DB
    Am J Physiol Cell Physiol; 2014 Mar; 306(6):C559-69. PubMed ID: 24401847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.
    Azam M; Nardi V; Shakespeare WC; Metcalf CA; Bohacek RS; Wang Y; Sundaramoorthi R; Sliz P; Veach DR; Bornmann WG; Clarkson B; Dalgarno DC; Sawyer TK; Daley GQ
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9244-9. PubMed ID: 16754879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function.
    Osorio y Fortéa J; Prina E; de La Llave E; Lecoeur H; Lang T; Milon G
    Immunol Rev; 2007 Oct; 219():66-74. PubMed ID: 17850482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imatinib mesylate blocks a non-Smad TGF-beta pathway and reduces renal fibrogenesis in vivo.
    Wang S; Wilkes MC; Leof EB; Hirschberg R
    FASEB J; 2005 Jan; 19(1):1-11. PubMed ID: 15629889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement receptor 3 mediates ruffle-like, actin-rich aggregates during phagocytosis of Leishmania infantum metacyclics.
    Dixit UG; Rodríguez NE; Polando R; McDowell MA; Wilson ME
    Exp Parasitol; 2021 Jan; 220():107968. PubMed ID: 32781093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variola and monkeypox viruses utilize conserved mechanisms of virion motility and release that depend on abl and SRC family tyrosine kinases.
    Reeves PM; Smith SK; Olson VA; Thorne SH; Bornmann W; Damon IK; Kalman D
    J Virol; 2011 Jan; 85(1):21-31. PubMed ID: 20962097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune serum from both susceptible and resistant strains of mice increases phagocytosis of Leishmania mexicana amazonensis by macrophages.
    Reis MG; Roters SB; Barral-Netto M
    Acta Trop; 1987 Sep; 44(3):339-42. PubMed ID: 2892370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.
    Wong S; McLaughlin J; Cheng D; Zhang C; Shokat KM; Witte ON
    Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17456-61. PubMed ID: 15505216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
    Letsiou E; Rizzo AN; Sammani S; Naureckas P; Jacobson JR; Garcia JG; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(3):L259-69. PubMed ID: 25480336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporary Shutdown of ERK1/2 Phosphorylation Is Associated With Activation of Adaptive Immune Cell Responses and Disease Progression During
    Oliveira LG; Souza-Testasicca MC; Ricotta TNQ; Vago JP; Dos Santos LM; Crepaldi F; Lima KM; Queiroz-Junior C; Sousa LP; Fernandes AP
    Front Immunol; 2022; 13():762080. PubMed ID: 35145518
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate.
    Schuster C; Forster K; Dierks H; Elsasser A; Behre G; Simon N; Danhauser-Riedl S; Hallek M; Warmuth M
    Blood; 2003 Jan; 101(2):655-63. PubMed ID: 12393654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
    Cameron P; McGachy A; Anderson M; Paul A; Coombs GH; Mottram JC; Alexander J; Plevin R
    J Immunol; 2004 Sep; 173(5):3297-304. PubMed ID: 15322192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disabling poxvirus pathogenesis by inhibition of Abl-family tyrosine kinases.
    Reeves PM; Bommarius B; Lebeis S; McNulty S; Christensen J; Swimm A; Chahroudi A; Chavan R; Feinberg MB; Veach D; Bornmann W; Sherman M; Kalman D
    Nat Med; 2005 Jul; 11(7):731-9. PubMed ID: 15980865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
    Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
    PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The ABL kinase inhibitor STI571 does not affect survival of hematopoietic cells after ionizing radiation.
    Uemura N; Griffin JD
    Blood; 2000 Nov; 96(9):3294-5. PubMed ID: 11203205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.